Nitric Oxide Protocols pp 225-234

Part of the Methods in Molecular Biology™ book series (MIMB, volume 279)

Adenovirus-Mediated Nitric Oxide Synthase Gene Transfer

  • Kathleen G. Raman
  • Richard A. Shapiro
  • Edith Tzeng
  • Melina R. Kibbe


The varied biological effects of nitric oxide (NO) have led to intense research into its diverse physiologic and pathophysiologic roles in multiple disease processes. It has been implicated in the development of altered vasomotor tone, intimal hyperplasia, atherosclerosis, impotence, host defense, and wound healing. Using the modern technologies of recombinant DNA and gene transfer using adenoviral vectors, the effects of NO derived from various NO synthase (NOS) enzymes can be studied in a variety of tissues and the therapeutic applications of NOS is possible. Such uses of NOS gene transfer have been investigated extensively in the vasculature where NO is critical to regulating vascular homeostasis. NOS gene therapy has the theoretical advantage of allowing NO delivery to be localized, thereby limiting potential adverse effects of NO. The benefits of adenoviral vectors in gene transfer include relatively high transduction efficiencies, both replicating and nonreplicating cells may be infected, and the high titers of adenovirus that can be produced. The methods described in this chapter include the cloning of the iNOS cDNA into a recombinant adenoviral vector, large-scale production of that vector AdiNOS preparation, and the use of the vector to transduce tissue in vitro and in vivo.

Key Words

AdiNOS nitric oxide synthase gene transfer 


  1. 1.
    McNamara, D. B., Bedi, B., Aurora, H., et al. (1993) L-arginine inhibits balloon catheter-induced intimal hyperplasia. Biochem. Biophys. Res. Commun. 193, 291–296.PubMedCrossRefGoogle Scholar
  2. 2.
    Lee, J. S., Adrie, C., Jacob, H. J., et al. (1996) Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury. Circ. Res. 78, 337–342.PubMedGoogle Scholar
  3. 3.
    Groves, P. H., Banning, A. P., Penny, W. J., et al. (1995) The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty. Cardiovasc. Res. 30, 87–96.PubMedGoogle Scholar
  4. 4.
    Marks, D. S., Vita, J. A., Folts, J. D., et al. (1995) Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J. Clin. Invest. 96, 2630–2638.PubMedCrossRefGoogle Scholar
  5. 5.
    Moncada, S., Palmer, R. M., and Higgs, E. A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109–142.PubMedGoogle Scholar
  6. 6.
    Stratford-Perricaudet, L. D. and Perricaudet, M. (1994). Gene therapy: the advent of adenovirus, in Gene Therapeutics: Methods and Applications of Direct Gene Transfer (Wolff, J. A., ed.), Birkhaeuser, Boston, pp. 344–362.Google Scholar
  7. 7.
    Horwitz, M. (1990) The adenoviruses, in Virology (Fields, B. N. and Knipe, D. M., eds.), Raven, New York, p. 1723.Google Scholar
  8. 8.
    Dorko, K., Freeswick, P. D., Bartoli, F., et al. (1994) A new technique for isolating and culturing human hepatocytes from whole or split livers not used for transplantation. Cell Transplant 3, 387–395.PubMedGoogle Scholar
  9. 9.
    Geller, D. A., Lowenstein, C. J., Shapiro, R. A., et al. (1993) Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci. USA 90, 3491–3495.PubMedCrossRefGoogle Scholar
  10. 10.
    Geller, D. A., Nussler, A. K., Di Silvio, M., et al. (1993) Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc. Natl. Acad. Sci. USA 90, 522–526.PubMedCrossRefGoogle Scholar
  11. 11.
    Shears, L. L., Kawaharada, N., Tzeng, E., et al. (1997) Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. J. Clin. Invest. 100, 2035–2042.PubMedCrossRefGoogle Scholar
  12. 12.
    Nykanen, A. I., Krebs, R., Saaristo, A., et al. (2003) Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis. Circulation 107, 1308–1314.PubMedCrossRefGoogle Scholar
  13. 13.
    Kibbe, M. R., Tzeng, E., Gleixner, S. L., et al. (2001) Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia. J. Vasc. Surg. 34, 156–165.PubMedCrossRefGoogle Scholar
  14. 14.
    Hayry, P., Mennander, A., Tiisala, S., et al. (1991) Rat aortic allografts: an experimental model for chronic transplant arteriosclerosis. Transplant Proc. 23, 611–612.PubMedGoogle Scholar
  15. 15.
    Shears, L. L., Kibbe, M. R., Murdock, A. D., et al. (1998) Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo. J. Am. Coll. Surg. 187, 295–306.PubMedCrossRefGoogle Scholar
  16. 16.
    Yamasaki, K., Edington, H. D., McClosky, C., et al. (1998) Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J. Clin. Invest. 101, 967–971.PubMedCrossRefGoogle Scholar
  17. 17.
    Tzeng, E., Billiar, T. R., Robbins, P. D., et al. (1995) Expression of human inducible nitric oxide synthase in a tetrahydrobiopterin (H4B)-deficient cell line: H4B promotes assembly of enzyme subunits into an active dimer. Proc. Natl Acad. Sci. USA 92, 11,771–11,775.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2004

Authors and Affiliations

  • Kathleen G. Raman
    • 1
  • Richard A. Shapiro
    • 1
  • Edith Tzeng
    • 1
  • Melina R. Kibbe
    • 1
  1. 1.Department of SurgeryUniversity of Pittsburgh Medical CenterPittsburgh

Personalised recommendations